This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Ceva Sante Animale, Ceva Sante Animale S.A.. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Jana Seele: Innovator in Vaccine Composition
Introduction
Jana Seele is a prominent inventor based in Hannover, Germany. She has made significant contributions to the field of vaccine development, particularly focusing on compositions that target infections in both pigs and humans. Her innovative work has led to the creation of a patented vaccine composition that showcases her expertise and dedication to improving health outcomes.
Latest Patents
Jana Seele holds a patent for a vaccine composition against infections. This patent describes a vaccine composition comprising an effective amount of at least one polypeptide selected from the group of IdeSsuis, rIdeSsuis, an analogue or a fragment thereof, or a polynucleotide encoding the same. The vaccine composition is utilized in the prophylactic, metaphylactic, or therapeutic treatment of infections in pigs or humans. This groundbreaking work highlights her commitment to advancing medical science.
Career Highlights
Throughout her career, Jana has worked with notable companies in the biotechnology and pharmaceutical sectors. She has been associated with Ceva Santé Animale and IDT Biologika GmbH, where she has contributed her expertise in vaccine development and research. Her work in these organizations has further solidified her reputation as an innovator in her field.
Collaborations
Jana has collaborated with esteemed colleagues, including Christoph Baums and Peter Valentin-Weigand. These partnerships have allowed her to enhance her research and contribute to significant advancements in vaccine technology.
Conclusion
Jana Seele's contributions to vaccine composition and her innovative spirit make her a noteworthy figure in the field of biotechnology. Her work continues to impact the health of both animals and humans, showcasing the importance of innovation in medical research.
